Efficacy and Tolerability of Lumiracoxib in the Treatment of Rheumatoid arthritis: A 13-Week, Randomized, Double-Blind Study | Charles Explorer

Efficacy and Tolerability of Lumiracoxib in the Treatment of Rheumatoid arthritis: A 13-Week, Randomized, Double-Blind Study

Publication

Abstract

Lumiracoxib, Rheumatoid arthritis

People